Tecan

Tecan
TalkTecan · CC BY-SA 3.0 · source
Name	Tecan
Type	Public
Industry	Laboratory automation
Founded	1980
Founder	Andreas Rung, Eveline Wild, Hans Beck, Heinz Sollberger
Headquarters	Research Park, Männedorf, Switzerland
Products	Liquid handling robots, microplate readers, automated workflows
Revenue	CHF (varies by year)
Employees	(varies)
Website	(omitted)

Tecan

Tecan is a global company specializing in laboratory automation and life science instrumentation. It designs and manufactures automated workflow solutions, microplate readers, and liquid handling platforms used across biomedical research, diagnostics, and pharmaceutical development. The company serves customers ranging from academic institutions to multinational corporations and clinical laboratories, integrating robotics, software, and consumables into high-throughput systems.

History

Founded in 1980 by Andreas Rung, Eveline Wild, Hans Beck, and Heinz Sollberger in Switzerland, the company grew during the 1980s and 1990s alongside advances at institutions and firms such as F. Hoffmann-La Roche AG, Genentech, Eli Lilly and Company, GlaxoSmithKline, and Pfizer. Tecan expanded through partnerships and acquisitions, mirroring industry trends seen at PerkinElmer, Agilent Technologies, Thermo Fisher Scientific, Beckman Coulter, and Becton, Dickinson and Company. Its corporate milestones include initial public offerings, strategic divestments, and entry into new markets influenced by collaborations with Novartis, Bristol-Myers Squibb, Merck Group, and Johnson & Johnson. Leadership changes have featured executives with backgrounds at Roche Diagnostics, Siemens Healthineers, and GE Healthcare. The company navigated regulatory environments shaped by agencies such as the European Medicines Agency, U.S. Food and Drug Administration, and Swissmedic while responding to market shifts tied to events like the Human Genome Project and the rise of high-throughput screening in drug discovery.

Products and Technology

Tecan’s portfolio centers on automated liquid handling instruments, microplate readers, and integrated laboratory automation systems comparable to products from Hamilton Company, Mettler Toledo, and PerkinElmer. Key platform types include automated pipetting workstations, plate hotels, and stackers used alongside consumables from Corning Inc., Greiner Bio-One, and Sartorius. Software solutions support laboratory information systems such as LabWare, Thermo Fisher SampleManager, and Benchling integrations. Optical detection modules incorporate technologies related to instruments by Molecular Devices and Bio-Rad Laboratories, enabling absorbance, fluorescence, and luminescence assays originating in methods developed by researchers at Cold Spring Harbor Laboratory, Broad Institute, and Max Planck Society. Tecan instruments are engineered to interface with standards from organizations like International Organization for Standardization and Clinical and Laboratory Standards Institute.

Applications and Markets

Tecan’s systems are deployed in academic research centers such as University of Cambridge, Harvard University, Stanford University, ETH Zurich, and Karolinska Institute for genomics, proteomics, and cell biology workflows. In pharmaceutical and biotech sectors—examples include Roche, Novartis, Regeneron Pharmaceuticals, and Amgen—platforms enable high-throughput screening, compound management, and ADME/Tox studies. Clinical diagnostics customers in hospital systems like Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital use automation for PCR setup, ELISA, and serology testing alongside devices from Roche Diagnostics and Abbott Laboratories. Environmental testing laboratories and food safety entities such as Eurofins Scientific adopt automation for microbiology and residue analysis. Emerging markets include personalized medicine initiatives at institutions like Memorial Sloan Kettering Cancer Center and cell therapy manufacturing programs at Novartis Institutes for BioMedical Research.

Corporate Structure and Operations

Tecan operates manufacturing and R&D sites in multiple countries and maintains sales and service networks reflecting global footprints similar to Siemens Healthineers and Thermo Fisher Scientific. Corporate governance aligns with practices seen at Nestlé, UBS Group, and Novartis AG with a board of directors and executive committee composed of executives experienced at Roche, GE Healthcare, and Siemens. Supply chain operations interact with component suppliers such as Intel Corporation for control systems, Sony-derived optics, and industrial partners like ABB Group for automation components. Distribution channels include direct sales and partnerships with regional distributors comparable to arrangements used by Waters Corporation and PerkinElmer. The company’s financial reporting is subject to Swiss corporate law and listings conventions similar to those of SIX Swiss Exchange-traded companies.

Research and Development

R&D emphasizes assay automation, robotics, and software, often collaborating with academic labs at ETH Zurich, University of California, San Francisco, and Imperial College London and industry partners including Illumina, Qiagen, and Roche Diagnostics. Project areas include liquid handling precision, integration with next-generation sequencing workflows pioneered by Illumina and Pacific Biosciences, and automation for CRISPR screening approaches associated with work at Broad Institute and The Salk Institute. The company files patents and engages with standards groups such as ISO and Clinical and Laboratory Standards Institute while attending industry conferences like Pittcon, SLAS International Conference, and BIO International Convention to showcase developments.

Controversies and Legal Issues

As with many life science suppliers, the company has encountered contractual disputes, intellectual property matters, and compliance inquiries analogous to cases involving Thermo Fisher Scientific and Agilent Technologies. Legal challenges have involved supplier agreements, warranty claims, and competition matters heard in civil courts and arbitration panels akin to disputes seen at Becton Dickinson and Beckman Coulter. Regulatory compliance scrutiny relates to device classification and laboratory standards enforced by agencies such as the U.S. Food and Drug Administration and European Medicines Agency. Public-facing controversies have sometimes arisen during industry consolidation trends involving firms like PerkinElmer and Danaher Corporation, prompting stakeholder and shareholder discussions comparable to those at other multinational precise-instrument manufacturers.

Category:Laboratory equipment companies Category:Swiss companies established in 1980